Recombinant CD80 (Galiximab Biosimilar) antibody

Catalog No. ABIN7597708

The Chimeric Chimeric anti-CD80 (Galiximab Biosimilar) antibody has been validated for . It is suitable to detect CD80 (Galiximab Biosimilar) in samples from Human.

Quick Overview for Recombinant CD80 (Galiximab Biosimilar) antibody (ABIN7597708)

Target: CD80 (Galiximab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Chimeric

Clonality: Chimeric

Conjugate: This CD80 (Galiximab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-CD80 (Galiximab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Galiximab Biosimilar Antibody

Specificity: CD80, BB1, T-lymphocyte activation antigen CD80, CD28LG, B7, CD28LG1, LAB7, Activation B7-1 antigen, CTLA-4 counter-receptor B7.1

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 lambda

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for CD80 (Galiximab Biosimilar)

Target: CD80 (Galiximab Biosimilar)

Alternative Name: Galiximab Biosimilar

Target Type: Biosimilar

Background: CD80, BB1, T-lymphocyte activation antigen CD80, CD28LG, B7, CD28LG1, LAB7, Activation B7-1 antigen, CTLA-4 counter-receptor B7.1

UniProt: P33681

CAS-No: 357613-77-5